Prenatal Testing Market Outlook 2015
Prenatal testing is an evolving sector, and the United States represents one of the largest markets in the world for fetal monitoring, diagnostics, and predictive tests. Rising health awareness and greater government initiatives are fuelling growth in this market as increasing chromosomal anomalies, such as Down’s syndrome, and Trisomy 16/18 are demanding more efficient prenatal care. According to our new research report, “Prenatal Testing Market Outlook 2015”, the US prenatal testing market represents a US$ 1.9 Billion industry which is growing to higher dimensions.
As per our comprehensive study, greater innovations and technological advancements can be expected in the market in the years to come. Based on our in-depth study and analysis of the industry, we have identified preliminary testing, first trimester screening, second trimester screening, chorionic villus sampling testing and amniocentesis testing as the major areas of testing in the US prenatal testing market. Amongst these, second trimester screening is expected to show greater penetration. It is estimated that the second trimester screening market will expand at a CAGR of around 4.4% between 2012 and 2015.
On studying the key market trends, we observed that the market for invasive tests will represent the opportunity area for industry players in near future. Our report also finds how the expanding age bracket and health insurance coverage (ObamaCare plan) will give a significant boost to the US prenatal testing market. With a view to providing extensive information and rational analysis of the market, we have thoroughly studied the regulatory environment as well as the competitive landscape. The comprehensive research work will help clients understand the market structure. The forecasts presented for various segments will give a clear understanding of the direction in which the industry is likely to progress in the coming years.
As per our comprehensive study, greater innovations and technological advancements can be expected in the market in the years to come. Based on our in-depth study and analysis of the industry, we have identified preliminary testing, first trimester screening, second trimester screening, chorionic villus sampling testing and amniocentesis testing as the major areas of testing in the US prenatal testing market. Amongst these, second trimester screening is expected to show greater penetration. It is estimated that the second trimester screening market will expand at a CAGR of around 4.4% between 2012 and 2015.
On studying the key market trends, we observed that the market for invasive tests will represent the opportunity area for industry players in near future. Our report also finds how the expanding age bracket and health insurance coverage (ObamaCare plan) will give a significant boost to the US prenatal testing market. With a view to providing extensive information and rational analysis of the market, we have thoroughly studied the regulatory environment as well as the competitive landscape. The comprehensive research work will help clients understand the market structure. The forecasts presented for various segments will give a clear understanding of the direction in which the industry is likely to progress in the coming years.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. FLOWCHART FOR PRENATAL TESTING
4. US PRENATAL TESTING MARKET OUTLOOK TO 2015
4.1 Preliminary Prenatal Testing
4.2 First Trimester Screening
4.3 Second Trimester Screening
4.4 Chorionic Villus Sampling (CVS) Testing
4.5 Amniocentesis Testing
5. KEY MARKET TRENDS
5.1 Non-Invasive Prenatal Diagnostics: Most Promising Niche
5.2 Preimplantation Genetic Diagnosis: Untapped Market with Huge Potential
5.3 Broadening Age Bracket and Health Insurance Coverage: Boosting Market
6. REGULATORY ENVIRONMENT
7. COMPETITIVE LANDSCAPE
7.1 Perkin-Elmer
7.2 Quest Diagnostics
7.3 Cedars-Serai
7.4 Labcorp
7.5 UCSF Prenatal Diagnostic Center
7.6 Mayo Clinic
2. RESEARCH METHODOLOGY
3. FLOWCHART FOR PRENATAL TESTING
4. US PRENATAL TESTING MARKET OUTLOOK TO 2015
4.1 Preliminary Prenatal Testing
4.2 First Trimester Screening
4.3 Second Trimester Screening
4.4 Chorionic Villus Sampling (CVS) Testing
4.5 Amniocentesis Testing
5. KEY MARKET TRENDS
5.1 Non-Invasive Prenatal Diagnostics: Most Promising Niche
5.2 Preimplantation Genetic Diagnosis: Untapped Market with Huge Potential
5.3 Broadening Age Bracket and Health Insurance Coverage: Boosting Market
6. REGULATORY ENVIRONMENT
7. COMPETITIVE LANDSCAPE
7.1 Perkin-Elmer
7.2 Quest Diagnostics
7.3 Cedars-Serai
7.4 Labcorp
7.5 UCSF Prenatal Diagnostic Center
7.6 Mayo Clinic
LIST OF FIGURES:
Figure 4-1: Prenatal Testing Market (Billion US$), 2010-2015
Figure 4-2: Preliminary Prenatal Testing Market (Million US$), 2010 -2015
Figure 4-3: First Trimester Screening Market (Million US$), 2010-2015
Figure 4-4: Second Trimester Screening Market (Million US$), 2010-2015
Figure 4-5: CVS Testing Market (Million US$), 2010-2015
Figure 4-6: Amniocentesis Testing Market (Million US$), 2010-2015
Figure 4-1: Prenatal Testing Market (Billion US$), 2010-2015
Figure 4-2: Preliminary Prenatal Testing Market (Million US$), 2010 -2015
Figure 4-3: First Trimester Screening Market (Million US$), 2010-2015
Figure 4-4: Second Trimester Screening Market (Million US$), 2010-2015
Figure 4-5: CVS Testing Market (Million US$), 2010-2015
Figure 4-6: Amniocentesis Testing Market (Million US$), 2010-2015
LIST OF TABLES:
Table 7-1: PerkinElmer - Key Prenatal Tests
Table 7-2: Quest Diagnostics - Key Prenatal Tests
Table 7-3: Cedars-Sinai Prenatal Diagnostic Center - Key Prenatal Tests
Table 7-4: Labcorp - Key Prenatal Tests
Table 7-5: UCSF Prenatal Diagnostic Center - Key Prenatal Tests
Table 7-6: Mayo Clinic - Key Prenatal Tests
Table 7-1: PerkinElmer - Key Prenatal Tests
Table 7-2: Quest Diagnostics - Key Prenatal Tests
Table 7-3: Cedars-Sinai Prenatal Diagnostic Center - Key Prenatal Tests
Table 7-4: Labcorp - Key Prenatal Tests
Table 7-5: UCSF Prenatal Diagnostic Center - Key Prenatal Tests
Table 7-6: Mayo Clinic - Key Prenatal Tests
